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Objective: To assess the risk of Parkinson’s disease
(PD) and update information on mortality from major
causes of death among a UK workforce who
manufactured paraquat (PQ) between 1961 and 1995.
There have been no previous studies of the incidence
of PD among PQ production workers, although much
epidemiological literature exists concerning the
relationship between pesticides and PD, and interest
has focused on PQ and its users.
Methods: The cohort included all employees who had
ever worked on any of the four plants at Widnes where
PQ was manufactured between 1961 and 1995, and
926 male and 42 female workers were followed
through 30 June 2009. Mortalities for males were
compared with national and local rates, including rates
for PD as a mentioned cause of death.
Results: Overall, 307 workers had died by 30 June
2009. One male death was due to PD, and no other
death certiﬁcate mentioned PD. At least 3.3 death
certiﬁcates of male employees would have been
expected to have mentioned PD (standardised
mortality ratio¼31; 95% CI 1 to 171). Personal
monitoring results were indicative that the exposure of
a PQ production worker on a daily basis was at least
comparable with that of a PQ sprayer or mixer/loader.
Reduced mortalities compared with local rates were
found for major causes of death.
Conclusions: The study provided no evidence of an
increased risk of PD, or increased mortalities from
other causes.
INTRODUCTION
A large body of epidemiological literature
exists concerning the relationship
between pesticides and Parkinson’s disease
(PD), mainly studies which have used a casee
control design.
1 2 Interest has focused on
paraquat (PQ) in part because of its struc-
tural similarity to 1-methyl-4-phenylpyridine
(MPP+), a metabolite of 1-methyl-4-phenyl-1,
2,3,6-tetrahydropyridine (MPTP). MPTP
itself is a contaminant of an unlicensed
recreational drug. Systemic exposure to
MPTP has been shown to cause permanent
parkinsonism in humans, non-human
primates and rodents as a result of its ability
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- Many epidemiological studies have been
conducted to investigate the relationship
between exposure to pesticides and Parkinson’s
disease (PD) since a report that the toxicant 1-
methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP) caused acute parkinsonism in a small
group of drug addicts, and several have focused
on paraquat (PQ) in part because of its structural
similarity to a toxic metabolite of MPTP.
- Caseecontrol studies provide much of the
information about a possible association
between PD and exposure to PQ, but most
have small numbers of subjects exposed to PQ
and/or limited exposure information.
- This study is the ﬁrst investigation of mortality from
PD among a cohort of PQ manufacturing workers.
Key messages
- The study provided no evidence of increased
mortalities from major causes of death. There
was no evidence of increased mortality (under-
lying and mentioned cause) from PD.
- Personal monitoring results indicated that
workers engaged in PQ production were likely
to have had a higher exposure to PQ than many
of the subjects in caseecontrol studies classiﬁed
as exposed to PQ.
Strengths and limitations of this study
- A major strength of the study is that it is a cohort
study. Exposure of workers to PQ is conﬁrmed
by comprehensive job histories and the avail-
ability of personal monitoring information.
- Limitations of the study include its size and
power, although the upper conﬁdence limit of the
standardised mortality ratio for mentions of PD is
relatively low (171). In addition, only information
from death certiﬁcates of deceased workers was
available, and it was not possible to study the
morbidity of the entire group.
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Open Access Researchto cross the bloodebrain barrier and cause toxicity after
being metabolised to MPP+.
3 In rodents, evidence of
PQ-induced parkinsonism is controversial, but some
investigators have reported a signiﬁcant, but partial,
reduction in dopinamergic neurons in the substantia
nigra of the mouse brain.
45Two recent reviews which
considered in detail the epidemiological and clinical
evidence for a causal association between PQ exposure
and PD have stated that it is inconclusive.
23However,
there have been no studies on the incidence of PD
among PQ production workers.
PQ was manufactured at Widnes in the northwest of
England between 1961 and 1995. During the late 1970s,
several shift process workers who had worked in one or
more of the plants were found to be suffering from skin
lesions, including solar keratosis, squamous-cell carci-
noma and Bowen’s disease. As part of a thorough
investigation, which included examination of current
and past employees and toxicological assessment of the
chemicals handled, a cohort of PQ production workers
was ascertained.
6 The cohort included all workers who
had ever been associated with the production of
4,49-bipyridyl or its subsequent conversion by quate-
rnisation to PQ, or the packaging of PQ solutions.
The investigation concluded that exposure to tarry
by-products was the most likely cause of the skin lesions.
A retrospective mortality study was later conducted of
an extended cohort that included all employees engaged
in PQ production at the Widnes site between 1961, when
production commenced, and 1983, with follow-up
through 31 December 1985.
7 The only suggestion of an
adverse health effect was a modest excess of lung cancer
deaths (13 observed, 10.5 expected deaths) which was
concentrated in the period of follow-up 15 years or more
after ﬁrst exposure (8 observed, 3.8 expected deaths).
No information was reported about mortality owing to
PD, as this was not a hypothesis of interest when the
study was conducted.
This report describes an extension and an update of
the cohort mortality study conducted by Paddle et al.
7
The primary objective of the study is to assess whether
there is any evidence of increased PD mortality as the
underlying cause of death or as a mentioned cause of
death. A secondary objective is to provide updated
information on mortality from major causes of death to
conﬁrm the absence of an exposure-related effect
reported by Paddle et al.
7
METHODS
Study population and follow-up
The investigation is a retrospective cohort mortality
study of workers who worked in PQ production at
Widnes, UK. Four plants using different processes were
used to manufacture PQ at the site: a high-temperature
sodium (HTS) plant (from 1961 to 1969, but used only
for quaternisation from early 1964); a magnesium
(MAG) plant (1962e1967); a low-temperature sodium
(LTS) plant (1966 until 1995 when manufacture of PQ at
Widnes ceased); and a plant utilising an ammonia
cyanide (AC) process (1985e1993). Small-scale prepro-
duction versions of the MAG and LTS plants were also
operated on the site for short periods.
The cohort included all employees who had ever
worked on any of these plants, and a further 217 male
employees and 10 female employees were added to
the cohort established by Paddle et al
7 in 1983 (729 male
employees and 32 female employees). However, 20 male
subjects included in the original cohort were excluded
because they were found to be not exposed (8) or they
had minimal identifying information including no date
of birth (12). The ﬁnal cohort consisted of 926 male
employees and 42 female employees.
The vital status of the cohort on 30 June 2009 was
ascertained from the Medical Research Information
Service of the National Health Service. The underlying
cause of death and other causes of death mentioned on
the death certiﬁcate were coded by the Ofﬁce of Popu-
lation Censuses and Surveys to the contemporaneous
revision of the International Classiﬁcation of Diseases
(ICD).
The initial investigation was approved by the British
Medical Association Ethical Committee, and Section 60
support for the update was granted by the UK Patient
Information Advisory Group.
Exposure assessment
Limited information is available to assess the exposures
to PQ of the workers in the cohort. However, 1330 static
monitoring results were collected between 1979 and
1993, and 100 personal monitoring results were
collected between 1983 and 1993. Only summary infor-
mation was available for static monitoring results
collected before 1987. There was insufﬁcient sampling
information available to use these measurements to
perform a quantitative exposure assessment.
Paddle et al
7 performed a limited qualitative exposure
assessment of male workers based on their highest
level of exposure to 11 substances including PQ.
The other substances included 2,29-bipyridyl 2,49-
bipyridyl, 4,49-bipyridyl, diglyme, pyridine, piperidine,
methyl chloride, dimethyl sulfate, benzene and tarry by-
products. Details were not provided in the published
paper, and no analyses were reported that utilised the
information. Approximately 300 of the 729 male workers
were assessed to have had high or medium exposure to
PQ. These included engineering maintenance workers
on the MAG and LTS plants, and process operators and
plant supervisors on all plants. At the time that the
qualitative exposure assessment was performed in the
mid-1980s, exposures to PQ on the LTS plant were stated
to be much lower than during the 1960s, and any
workers recruited after that time were unlikely to have
experienced exposures to PQ that would have been
categorised as high or medium. Exposure levels were not
assessed for research staff, plant laboratory workers (day
and shift) and technical administrative staff (day and
shift), but their exposure was likely to have been low.
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The observed number of deaths from selected causes
and groups of causes was compared with the expected
number calculated on the basis of national and local age
and period-speciﬁc mortalities. The standardised
mortality ratio (SMR) was calculated as the ratio of the
observed to the expected deaths, expressed as
a percentage. OCMAP-PLUS
8 was used to sum person-
years within categories of age (5 year intervals) and
calendar period (generally 5-year intervals to conform
with changes in the ICD), and to compute SMRs and
their 95% CIs. Female workers were not included in the
SMR analyses because their numbers were small;
however, their cause of death information was reviewed.
Mortalities for England and Wales were used for
comparison, and a comparison with local mortalities was
made by combining information available between 1981
and 2008 for Halton Unitary Authority (where the plants
were located) and the seven surrounding local districts.
In local comparisons, mortalities for England and Wales
were used for the time period 1960e1980.
Mortalities were also calculated for PD using all certi-
ﬁed causes of death listed on the death certiﬁcate
(conventionally termed ‘mentions’), as well as rates for
PD as the underlying cause of death. Information on
‘mentions’ was available for the period 1993e2008, but it
was not possible for the UK Ofﬁce for National Statistics
to supply such information before 1993. A conservative
estimate of the number of deceased workers whose
death certiﬁcate would be expected to mention PD was
calculated using mortalities for PD as an underlying
cause of death to 1992 and a mentioned cause of death
after 1992.
Analyses were performed for the entire cohort and the
subcohort of workers who had worked for a minimum of
3 months. Mortality owing to PD was also examined in
the subcohort of workers who were assessed to have had
a high or medium exposure in the original mortality
investigation. Duration of employment and latency were
treated as time-related variables with the values calcu-
lated for each person-year under observation. A subject
was allowed to contribute to more than one stratum in
each analysis.
RESULTS
Table 1 shows the plants where male subjects had
worked. Over 40% had worked on the two earliest plants
(HTS and MAG), and almost half had only worked on
the LTS plant. A total of 118 workers were assessed to
have held jobs that entailed high exposure to PQ, and
a further 202 held jobs that entailed medium exposure
to PQ. Table 2 shows the vital status of the cohort on 30
June 2009. A total of 10 workers (1.0%) had emigrated
or joined the armed forces, and a further nine workers
(1.0%) were lost to follow-up. The average age of male
employees at ﬁrst exposure was 32.8 years, and they
contributed 28963 person-years of follow-up.
Only grouped arithmetic means were available for
monitoring results collected before 1987. The 1073
static monitoring results had a mean of 0.0120 mg of
PQ ion/m
3 (range <0.002e1.005 mg PQ ion/m
3), and
the mean of the six personal monitoring results available
for this period, all collected for workers in a single
location during 1 month, was 0.012 mg PQ ion/m
3 (max
0.4 mg PQ ion/m
3). The geometric mean of 257 static
monitoring results collected between 1987 and 1993 was
0.00328 mg PQ ion/m
3 (range <0.00012e0.044 mg PQ
ion/m
3), and the geometric mean of the 94 personal
monitoring results collected during the same time
period was 0.00258 mg PQ ion/m
3 (range
<0.0006e0.04 mg PQ ion/m
3).
Table 3 shows the SMRs for the major causes of death
and those of initial interest. Local mortalities for PD
were very similar to England and Wales mortalities, and
only comparisons with mortalities for England and Wales
are described in the text. There was only one death from
PD as the underlying cause among male workers (1.8
expected), and the death certiﬁcate of this worker was
the only one that mentioned PD. At least 3.3 death
certiﬁcates of male workers would have been expected to
have mentioned PD (SMR¼31; 95% CI 1 to 171). None
of the deceased workers in the high-PQ-exposure group
had a death certiﬁcate that mentioned PD (0.5 expected
mentions), but the one worker whose death certiﬁcate
mentioned PD had held a job entailing medium expo-
sure to PQ (1.1 expected mentions). None of the death
certiﬁcates of the 15 deceased female workers
Table 1 Plants where male subjects were employed
Plants N (%)
HTS only 79 (8.5)
HTS and MAG 17 (1.8)
HTS, MAG and LTS 27 (2.9)
HTS and LTS 18 (1.9)
HTS, LTS and AC 1 (0.1)
MAG only 79 (8.5)
MAG and LTS 147 (15.9)
MAG, LTS and AC 10 (1.1)
LTS only 462 (49.9)
LTS and AC 75 (8.1)
AC only 11 (1.2)
Total 926 (100.0)
AC, ammonia cyanide; HTS, high-temperature sodium; LTS, low-
temperature sodium; MAG, magnesium.
Table 2 Vital status on 30 June 2009
Vital status Males Females
Alive 616 26
Dead 292 15
Emigrated or joined armed
forces
10 e
Lost to follow-up 8 1
Person years of follow-up 28963 e
Total 926 42
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Parkinson’s disease mortality among paraquat workersmentioned PD. Mortality from all neurological diseases
(SMR¼16, 1 death) was signiﬁcantly lower than expected
(p<0.05), and there were no mentions of secondary PD
disease and other movement disorders, or other neuro-
logical diseases on the death certiﬁcates of male and
female employees.
Compared with mortalities for England and Wales,
deaths from all causes of death were signiﬁcantly lower
than expected (p<0.05), and deaths due to all cancers,
heart disease, cerebrovascular disease and non-malig-
nant respiratory disease were all lower than expected. A
similar pattern was seen when comparisons were made
with local mortalities, with deaths from all causes of
death, heart disease and non-malignant respiratory
disease all signiﬁcantly lower than expected (p<0.01).
Lung-cancer mortality was also lower than expected,
especially when compared with local mortalities
(SMR¼73; 95% CI 49 to 105).
In addition, to the 10 causes of death shown in table 3,
comparisons with England and Wales mortalities were
also made for a further 52 causes of death. Deaths from
none of these causes of death were signiﬁcantly higher
than expected at a p¼0.1 level, but deaths from cancer
of the rectum and cancer of the colon were signiﬁcantly
lower than expected at this signiﬁcance level. In total,
there were two deaths from colorectal cancer (SMR¼19;
95% CI 3 to 58). Mortality from nephritis and nephrosis
was of interest because of the acute renal toxicity of PQ,
but no deaths were observed (1.8 expected). Some
workers were potentially exposed to benzene, but there
was no increase in leukaemia mortality (SMR¼91; 95%
CI 9 to 272, 2 observed deaths) or mortality from
lymphohaematopoietic cancers (SMR¼81; 95% CI 30 to
177, 6 observed deaths).
Mortality patterns were also examined among the
group of 320 workers who had ever held a job entailing
high or medium exposure to PQ. Most of these workers
started work on PQ production plants in the 1960s, and
159 of them had died by the end of the follow-up.
Compared with local mortalities, the all-cause mortality
was lower than expected (SMR¼89; 95% CI 76 to 105),
deaths due to malignant neoplasms were close to
expected (SMR¼103; 95% CI 78 to 135) among these
workers, and there was no evidence of any trends with
duration of exposure (<1 year, 1e5 years, >5 years).
DISCUSSION
This study has shown no evidence of increased mortality
(underlying and mentioned cause) from PD among PQ
production workers. Prior to this investigation, infor-
mation about a possible association between PD and PQ
was available from a small number of epidemiological
studies, mainly studies which have used a caseecontrol
design. This is the ﬁrst study of workers who manufac-
tured PQ. A comprehensive review has recently been
conducted of the studies speciﬁc to PQ and the risk of
PD, and other studies which provide data on the issue of
pesticide exposure and the risk of PD.
3 The authors
concluded that the evidence is fragmentary and insufﬁ-
cient to establish whether exposure to PQ increases the
risk for PD. The PQ-speciﬁc studies include one cohort
study,
9 eight caseecontrol studies
10e17 and a cross-
sectional study.
18 Another caseecontrol study tested the
geneeenvironment hypothesis that dopamine-trans-
porter genetic variants alone and in combination with
residential exposure to PQ and maneb increase suscep-
tibility to PD.
19 In general, information from the case-
econtrol and cross-sectional studies is limited, as most
had small numbers of subjects exposed to PQ and poor
exposure information,
23but three caseecontrol studies
provide some evidence of association and are discussed
in more detail.
10 12 15







SMR (95% CI) SMR (95% CI)
001e999 All causes of death 292 88* (78 to 98) 76** (68 to 86)
140e208 All malignant neoplasms 99 99 (81 to 121) 85 (69 to 104)
160e165 Respiratory system 30 91 (62 to 131) 72 (49 to 103)
162 Bronchus, trachea and
lung
29 93 (62 to 133) 73 (49 to 105)
320e359 Neurological diseases 1 16* (0 to 88) 16* (0 to 88)
332.0 Parkinson’s disease 1 55 (1 to 309) 61 (2 to 340)
332.0 Parkinson’s disease
(mentioned)z
1 31 (1 to 171) 32 (1 to 176)
390e398, 402, 404,
410e429
All heart disease 92 85 (68 to 104) 74** (60 to 91)
430e438 Cerebrovascular disease 22 89 (56 to 135) 80 (50 to 121)
460e519 Non-malignant respiratory
disease
28 76 (50 to 109) 59** (39 to 85)
800e999 External causes of death 14 100 (55 to 168) 100 (55 to 168)
*p<0.05, **p<0.01; SMR signiﬁcantly different from 100.
yHalton Unitary Authority and the seven surrounding County and Unitary districts.
zMentioned cause of death (1993e2008); underlying cause of death (1960e1992).
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Parkinson’s disease mortality among paraquat workersA small Canadian caseecontrol study reported that out
of 57 cases of PD and 122 controls, four cases versus
none in the control group reported ever handling PQ.
12
However, there was no evidence of an association in
a later study conducted by the same group in the same
region of Canada, and in which the investigators noted
that they attempted to improve on their previous
caseecontrol study by including features designed to
improve and control patient recall.
13
Another caseecontrol study conducted in Taiwan with
120 cases and 240 controls reported a statistically
signiﬁcant OR of 3.22 for PQ use.
15 In analyses
adjusted for other potential risk factors, the ORs for 1 to
19 years of PQ use and 20 or more years of PQ use, as
compared with no use of PQ, were 0.96 (95% CI 0.24 to
3.88) and 6.44 (95% CI 2.41 to 17.2), respectively.
However, these ﬁndings did not differ greatly from those
reported by the authors for herbicide/pesticide use.
In addition, the authors did not deﬁne what they
meant by PQ use and made no apparent attempt to
differentiate between residential and occupational
use, or incorporate information on time spent spraying
each year. Hence, duration of use cannot be equated to
dose.
A further study of 368 incident PD cases and 341
population controls from California reported that resi-
dential ambient exposure to both PQ and maneb
increased PD risk by 75% (95% CI 1.13 to 2.73).
10 The
authors based their exposure estimates on Californian
land-use maps and pesticide-use reports made for
1-square-mile tracts of land deﬁned by the US Public
Land Survey System. However, they could only infer that
residential exposure to PQ had occurred, and it is clear
that the speciﬁcity of their method is low, as indicated by
the fact that over 60% of controls were presumed to have
had residential exposure to PQ, even though they
resided in counties with largely urban populations. The
authors presumed that PQ had been used within 500m
of a subject’s home (residential exposure) if Californian
land-use maps showed that a type of crop grown in
a ﬁeld within that distance of the house had been
reported to have been treated by PQ in the Public Land
Survey System section where the ﬁeld was located.
However, the reported application of PQ could have
been carried out as far away as 2256 m (the length of the
diagonal of a square-mile section) from the ﬁeld of
interest, which in itself might have been 500m from the
subject’s home. Although the bias is not differential, it
will have resulted in much inﬂated statistical signiﬁ-
cance. Furthermore, the measure of residential exposure
(a weighted sum of application rates) is not related to
the amount of the pesticide applied in a zone around
a residence. However, another group has used the
same Californian data resources to derive an estimate of
the amount of pesticide used, and this modiﬁcation
offers considerable potential for future epidemiology
studies, especially if occupational exposure can be
incorporated.
20
A prospective cohort study forming part of the US
Agricultural Health Study includes 84738 private pesti-
cide applicators and their spouses recruited between
1993 and 1997, and followed up to 1999e2003.
9 A total
of 78 incident cases of PD were diagnosed during follow-
up, and 11 of these had reported PQ use as part of the
detailed information collected from participants during
the recruitment phase on their personal lifetime pesti-
cide use. The RR for incident PD was 1.0 (95% CI 0.5 to
1.9). A further 83 cases of PD were identiﬁed at
recruitment (prevalent cases), and 14 reported PQ use.
The RR for prevalent PD was 1.8 (95% CI 1.0 to 3.5). The
authors were not able to explain the reason for differ-
ences in results for prevalent and incident cases, but the
analysis based on prevalent PD is clearly more vulnerable
to differential recall bias than that based on incident
cases. Overall, greater weight can be given to the inci-
dent PD ﬁnding than risk estimates from the other
PQ-speciﬁc studies because of the better quality of
exposure information and the fact that it was collected
before diagnosis.
The present study of workers engaged in the manu-
facture of PQ has the advantage of being a cohort study,
with no potential for recall bias. In addition, compre-
hensive job histories enable workers with the highest
potential for exposure to be identiﬁed, whereas most of
the PQ-speciﬁc studies have no satisfactory information
about the deﬁnition, duration and extent of exposure.
A further strength of the study is the likely higher
exposure of workers engaged in PQ production than
many of the subjects in caseecontrol studies classiﬁed as
exposed to PQ. The geometric mean of the 94 personal
monitoring results collected at Widnes between 1987
and 1993, although well below the UK occupational
exposure limit of 0.08 mg/m
3 (8 h TWA, respirable
fraction), equates to a mean daily intake of 25.8 mgP Q
ion (assuming 10 m
3 of air breathed during a shift), and
exposure levels were almost certainly higher during
earlier years of production. In contrast, a recent study of
PQ excreted over 24 h in the urine of Costa Rican farm
workers who mixed, loaded or sprayed PQ reported
a geometric mean urinary PQ level of 3.0 (GSD 3.07)
mg/24 h on application days.
21 Although these values
cannot be directly equated, the predominant route of
excretion is via urine, and the data are indicative that the
exposure of a PQ production worker on a daily basis is at
least comparable with that of a PQ sprayer. In addition,
workers engaged in PQ production had the potential to
be exposed daily, whereas workers employed as sprayers
are unlikely to have sprayed PQ on a daily basis, and
many subjects described as PQ users in caseecontrol
studies may have used PQ on an occasional basis only.
Only one other study has assessed exposure using
measurements of PQ excreted in the urine over 24 h,
a more accurate representation of the amount absorbed
on a daily basis than a urine spot sample. The investi-
gators failed to detect urinary PQ in a group of Sri
Lankan tea plantation workers,
22 and Lee et al
21 noted
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Parkinson’s disease mortality among paraquat workersthere was also a low frequency of urinary PQ detection in
studies utilising spot urine sampling, but this was likely
to be related to a high limit of detection.
A perceived limitation of this study is that cases of PD
are identiﬁed only if PD is a certiﬁed cause of death
listed on their death certiﬁcate. However, although it is
widely regarded that most patients with PD die of its
complications and not the disease, the limited informa-
tion available suggests that PD is coded as the underlying
cause of death of many patients and is mentioned on the
death certiﬁcates of the majority of patients. A UK study
reported that PD was coded as the underlying cause of
death of 63 (37%) of 171 people with idiopathic PD (108
men and 63 women) but was recorded in either part I or
part II of the death certiﬁcates of 130 (76%),
23
suggesting that few of the deceased workers in the
present study are likely to have had PD which was not
mentioned on their death certiﬁcates. There was no
evidence that the likelihood of PD being a mentioned
cause of death had changed during the study period
(1966e1997), differed between the sexes or varied with
age at death. Studies from Scandinavia and the USA have
generally reported slightly lower instances of PD being
a mentioned cause of death for individuals with PD,
ranging from 55% to 70%.
24e29
The feasibility of conducting a morbidity study of the
whole group was also considered. Living workers were on
average almost 7 years younger than deceased workers
(the average age at death of deceased workers was
69 years). It was also expected that the participation rate
would not be high, as many had been enrolled in
a surveillance scheme because of the skin lesion problem
identiﬁed in the late 1970s, but only about a half still
attended regularly. At best, a morbidity study was only
expected to identify about twice as many cases of PD as
a mortality study. However, a large comparison group
would be required to estimate the background incidence
rate and achieve any improvement in power. It was esti-
mated that the mortality study would have 80% power to
detect a 2.84 increase in risk (based on an estimate that
four deceased workers would have a death certiﬁcate
that mentioned PD). This is adequate power to detect
the OR of 3.22 for PQ use reported by the Taiwanese
investigation,
15 and it was decided that performing
a morbidity study would be not worthwhile unless the
results of the mortality investigation indicated an
increased risk of PD.
Another limitation of the study is that rates for
mentions of PD on death certiﬁcates could be calculated
only from 1993 onwards, and the analysis of mentions of
PD had to use underlying cause of death rates before
1993. However, this resulted in an underestimate of the
number of expected mentions of PD. Two UK studies
provide some information about trends in mentions of
PD on death certiﬁcates before 1993
30 31 and suggest
that the age-standardised male mortality for mentions of
PD was about 10% higher between 1985 and 1992 than
between 1993 and 2000.
31 Making this assumption, the
expected number of mentions of PD on the death
certiﬁcates of workers in the cohort is increased from 3.3
to 3.5. This latter ﬁgure includes 0.13 expected deaths
due to PD before 1985 and suggests that the true
expected number of PD mentions over the study period
is between 3.6 and 3.7, as the expected number of death
certiﬁcates of workers with PD as a mentioned cause for
the period of follow-up 1985e2009 is approximately
twice the number of expected deaths with PD as the
underlying cause.
A full quantitative exposure assessment was not
conducted. No quantitative information about PQ
exposure was available before 1979, but the report of the
qualitative exposure assessment performed in the mid-
1980s noted that exposures to PQ on the LTS plant were
much lower then than during the 1960s. Static moni-
toring results collected between 1987 and 1993 varied
little between sampling locations but were about three
times lower on average than those collected between
1979 and 1986. Hence, it seems likely that PQ exposure
levels continued to fall between 1979 and 1993, even
though location information was not available for
samples collected between 1979 and 1993. In the case of
PD, the absence of additional quantitative exposure
information was not a limitation, as there was only one
mention of PD on the death certiﬁcates of deceased
workers. The worker who died of PD was assessed as
having medium exposure to PQ.
Lung cancer was also of interest because the initial
investigation reported a modest excess (13 observed,
10.5 expected deaths).
7 However, there was no evidence
of an excess of lung cancer in the update, especially
when compared with local mortalities (SMR¼73; 95% CI
49 to 105). Paddle et al
7 noted that the excess in their
study was concentrated in the period of follow-up
15 years or more after ﬁrst exposure. The excess appears
to have been conﬁned to a small group of HTS/MAG
process workers with <1 year of exposure, and restricted
to the period 15e30 years after ﬁrst exposure. There was
a small, but non-signiﬁcant excess among these short-
term workers (4 observed, 1.3 expected based on local
rates), but no new lung cancer deaths had occurred
during the additional period of follow-up. There was no
excess of lung-cancer deaths among HTS/MAG process
workers with longer periods of exposure. Other investi-
gations have reported increased mortality from lung
cancer among short-term workers,
32 and the excess is
unlikely to be related to occupation.
In conclusion, there was no evidence of an increased
incidence of PD among PQ production workers based
on mentions of PD on the death certiﬁcates of workers
who had died. In addition, there was no evidence of
adverse mortality due to other causes including lung
cancer mortality.
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